Atlas Trials

Fespixon Cream for the Treatment of Chronic Diabetic Foot Ulcers (TEXAS 1A, 2A) in Dialysis Patients

Clinical trial NCT05338463 · COMPLETED

Trial details

NCT number
NCT05338463
Sponsor
Cathay General Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Diabetic Foot Ulcer
Start date
2021-12-01
Primary completion
2024-03-22
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.